Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
ID: 351216Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351216

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-048.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a grant opportunity titled "Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce" (R25), aimed at supporting educational activities that promote diversity in the biomedical and behavioral sciences. This initiative specifically targets underrepresented groups and encourages the development of research experiences and skills that facilitate the transition of young scientists into professional careers in substance use and addiction research. The program emphasizes the importance of diverse perspectives in scientific inquiry to foster innovation and address health disparities, particularly among American Indian and Alaska Native populations. Interested applicants can apply for funding up to $250,000 annually for projects lasting up to five years, with applications due by February 14, 2024. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-048.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-048-Full-Announcement.html
    PAR-24-048.html
    The National Institutes of Health (NIH) announces the funding opportunity titled "Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce" (R25). This initiative aims to support educational activities promoting diversity in biomedical and behavioral sciences, specifically targeting underrepresented groups. The program encourages research experiences and skills development courses to nurture young scientists' transition to professional careers in substance use and addiction research. Key aspects include a funding cap of $250,000 annually for projects lasting up to 5 years, with applications due by February 14, 2024. Eligible institutions include higher education entities, non-profits, and state and local governments. Applications must detail research education programs that emphasize mentoring and innovative educational methods, aligning with the NIH's mission to diversify the research workforce. The announcement highlights the importance of diverse perspectives in scientific inquiry, fostering innovation and addressing health disparities, particularly among American Indian and Alaska Native populations. Applications must demonstrate a clear plan for participant recruitment and retention, training in responsible research conduct, and strategies to enhance workforce diversity. Successful applicants will contribute significantly to advancing NIH's goals in substance use and addiction research while enhancing public trust and health outcomes across communities.
    Similar Opportunities
    NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Research Education Program for Clinical Researchers and Clinicians under Funding Opportunity Number PAR-25-204, aimed at enhancing the training of clinicians and clinical researchers in substance use disorder (SUD) research. This program seeks to address the shortage of qualified professionals in the field by supporting educational activities that develop skills and provide hands-on research experiences, particularly targeting underrepresented groups in the workforce. With a budget of up to $350,000 annually for a project duration not exceeding five years, the program is open for applications starting February 11, 2025. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Alcohol and Other Substance Use Research Education Programs for Health Professionals." This initiative aims to support educational activities that enhance healthcare professionals' understanding of biomedical, behavioral, and clinical research related to alcohol and substance use disorders, with a focus on outreach to disseminate research findings effectively. The program encourages diverse participation and aims to recruit healthcare providers for education on current and emerging knowledge in addiction science, with funding available for projects not exceeding $250,000 per year for up to four years. Interested applicants should submit their proposals electronically through Grants.gov by May 25, 2026, and can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), is offering a federal grant opportunity titled "Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)." This program aims to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce by providing research experiences and related opportunities for individuals from underrepresented groups. The initiative is crucial for addressing health disparities in cardiovascular, pulmonary, and hematologic diseases by fostering a diverse scientific workforce. Interested applicants can apply for funding up to $175,000 per year for a maximum of five years, with applications opening on December 29, 2023, and a submission deadline of August 19, 2026. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-25-001.html.
    NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) to support institutional research career development programs aimed at clinician scientists. This grant is designed to provide intensive supervised research training and career development experiences, ultimately leading to research independence in the field of substance use and substance use disorders. The program encourages applications focusing on various scientific areas, including neuroimaging, genetics, medication development, and implementation science, among others. Interested applicants from private institutions of higher education should prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis post date of July 3, 2025, and a close date of August 5, 2025. For further inquiries, applicants can contact Lindsey Friend, Ph.D., at NIDA via email at NIDATraining@nida.nih.gov or by phone at 301-402-1428.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Substance Use/Substance Use Disorder Dissertation Research Award (R36), aimed at supporting doctoral candidates for up to two years in their dissertation research related to substance use disorders. This grant, under the National Institute on Drug Abuse (NIDA), encourages applications from diverse backgrounds and focuses on advancing knowledge in prevention, diagnosis, and treatment of substance misuse and related health outcomes, excluding independent clinical trials. Eligible applicants can receive up to $50,000 per year for innovative research aligned with NIDA’s strategic plan, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" to support doctoral candidates in completing their dissertation research projects related to substance use disorders. This funding initiative aims to enhance the pool of talented researchers in the field by providing grants of up to $50,000 per year for direct costs over a maximum of two years, with a focus on projects that align with the National Institute on Drug Abuse (NIDA) strategic priorities. Applications are particularly encouraged from individuals who can contribute to diversifying the research workforce, and interested candidates must submit their applications by October 16, 2023, or on February 16 and June 16, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Research Education Program, aimed at advancing the careers of a diverse research workforce through educational activities. This program specifically targets individuals from underrepresented backgrounds in the biomedical and behavioral sciences, focusing on skills development courses, research experiences, and mentoring activities, while explicitly excluding clinical trials. With a funding opportunity number of PAR-23-282, applicants can request up to $351,000 annually for a maximum of five years, with the application period opening on December 26, 2023, and a submission deadline of May 25, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage for additional details.
    Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)," aimed at advancing translational research in the field of substance use. This initiative encourages researchers to engage in a two-phase research process, starting with an R61 planning phase lasting up to two years, followed by an R33 phase for larger studies that may extend up to four years, contingent upon meeting specific milestones. The program emphasizes the importance of community stakeholder engagement and mandates a Plan for Enhancing Diverse Perspectives (PEDP) in all proposals to ensure inclusivity in research development. Interested applicants can find more information and submit their proposals by December 14, 2026, and should direct inquiries to grantsinfo@nih.gov.
    Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mechanism for Time-Sensitive Substance Use Research" under the National Institute on Drug Abuse (NIDA). This grant, designated as R21, aims to support pilot, feasibility, and exploratory research addressing urgent issues in substance use epidemiology and health services, particularly in response to sudden increases in substance misuse and emerging public health challenges. Eligible applicants include a wide range of entities such as educational institutions, governmental bodies, and nonprofit organizations, with a budget cap of $275,000 over two years. Interested parties must submit their applications by September 9, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Mentored Clinical Scientist Development Program Award (K12), aimed at advancing research in substance use and substance use disorders (SUD). This funding opportunity supports clinician scientists through intensive mentorship and research experiences over a period of 3-4 years, requiring eligible scholars to hold a doctoral degree and dedicate at least 75% of their effort to research and career development. The program emphasizes the importance of fostering a diverse scientific workforce and requires applicants to include a recruitment plan to enhance diversity, alongside a structured career development and research plan aligned with NIDA’s mission. Interested applicants should note that the application submission window opens on February 6, 2024, with a funding ceiling of $750,000 per year for direct costs. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at NIDA's funding announcement.